Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wright Petitions FDA To Deny Smith & Nephew’s Hip Resurfacing PMA

This article was originally published in The Gray Sheet

Executive Summary

Approval of Smith & Nephew's PMA for its Birmingham hip resurfacing system would set a "dangerous precedent," orthopedic competitor Wright Medical contends in written comments to FDA

You may also be interested in...



Wright Looks To New Management, Hip Resurfacing To Get Back On Track

Wright Medical Group believes a change in its management and release of the Conserve Plus hip resurfacing system could reverse the firm's recent sales slide

Wright Looks To New Management, Hip Resurfacing To Get Back On Track

Wright Medical Group believes a change in its management and release of the Conserve Plus hip resurfacing system could reverse the firm's recent sales slide

Panel Supports Smith & Nephew’s Birmingham Hip Resurfacing System

FDA's Orthopaedic & Rehabilitation Devices Panel narrowly recommended approval for Smith & Nephew's Birmingham Hip Resurfacing system Sept. 8, provided that the firm conducts a postmarket study

Related Content

UsernamePublicRestriction

Register

MT022935

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel